The fatality is considered to be related to the drug treatment, according to the biotech, which is developing the STING agonist in collaboration with GSK under the terms of a $1.3 billion option ...

Samjin Pharmaceutical Co. Ltd. has disclosed stimulator of interferon genes protein (STING; TMEM173) agonists reported to be useful for the treatment of cancer, allergy, autoimmune diseases and ...

An innovative nano-immune agonist has been developed to significantly ... via the synergistic action of cuproptosis and cGAS-STING enhanced immune response Go to source). The study, recently ...